- Home
- XERS vs XRX Comparison
XERS vs XRX Comparison
Compare XERS & XRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- XRX
- Stock Information
- Founded
- XERS 2005
- XRX 1906
- Country
- XERS United States
- XRX United States
- Employees
- XERS N/A
- XRX N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- XRX Computer peripheral equipment
- Sector
- XERS Health Care
- XRX Technology
- Exchange
- XERS Nasdaq
- XRX Nasdaq
- Market Cap
- XERS 752.7M
- XRX 674.2M
- IPO Year
- XERS 2018
- XRX N/A
- Fundamental
- Price
- XERS $5.29
- XRX $4.91
- Analyst Decision
- XERS Strong Buy
- XRX Sell
- Analyst Count
- XERS 6
- XRX 3
- Target Price
- XERS $6.25
- XRX $9.00
- AVG Volume (30 Days)
- XERS 2.2M
- XRX 3.5M
- Earning Date
- XERS 08-07-2025
- XRX 07-24-2025
- Dividend Yield
- XERS N/A
- XRX 10.28%
- EPS Growth
- XERS N/A
- XRX N/A
- EPS
- XERS N/A
- XRX N/A
- Revenue
- XERS $222,551,000.00
- XRX $6,176,000,000.00
- Revenue This Year
- XERS $35.03
- XRX $0.80
- Revenue Next Year
- XERS $18.31
- XRX $14.78
- P/E Ratio
- XERS N/A
- XRX N/A
- Revenue Growth
- XERS 29.88
- XRX N/A
- 52 Week Low
- XERS $2.10
- XRX $3.45
- 52 Week High
- XERS $6.07
- XRX $12.29
- Technical
- Relative Strength Index (RSI)
- XERS 62.91
- XRX 43.70
- Support Level
- XERS $5.00
- XRX $4.97
- Resistance Level
- XERS $5.49
- XRX $5.90
- Average True Range (ATR)
- XERS 0.24
- XRX 0.27
- MACD
- XERS 0.08
- XRX -0.06
- Stochastic Oscillator
- XERS 79.38
- XRX 10.75
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About XRX Xerox Holdings Corporation
Xerox Holdings Corp is an original equipment manufacturing and software company. Xerox operates in one segment--design, development, and sale of printing technology and related solutions--while deriving 60% of its revenue from the U.S. and 40% from international markets. The company is an OEM of multifunction printers, or MFPs (printers that can print, copy, and scan), focusing on large enterprise markets. Apart from equipment, the company provides post-sales services like managed print services help to bring smart servicing and efficiencies to how employers use their print/copy equipment. Xerox is attempting to enter new markets like digital print packaging solutions and printed electronics.